![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 602 |
FusionGeneSummary for ACTN4_RYR1 |
![]() |
Fusion gene information | Fusion gene name: ACTN4_RYR1 | Fusion gene ID: 602 | Hgene | Tgene | Gene symbol | ACTN4 | RYR1 | Gene ID | 81 | 6261 |
Gene name | actinin alpha 4 | ryanodine receptor 1 | |
Synonyms | ACTININ-4|FSGS|FSGS1 | CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR | |
Cytomap | 19q13.2 | 19q13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | alpha-actinin-4focal segmental glomerulosclerosis 1non-muscle alpha-actinin 4 | ryanodine receptor 1central core disease of muscleprotein phosphatase 1, regulatory subunit 137ryanodine receptor 1 (skeletal)sarcoplasmic reticulum calcium release channelskeletal muscle calcium release channelskeletal muscle ryanodine receptortyp | |
Modification date | 20180522 | 20180523 | |
UniProtAcc | O43707 | P21817 | |
Ensembl transtripts involved in fusion gene | ENST00000252699, ENST00000424234, ENST00000390009, ENST00000497637, | ENST00000355481, ENST00000360985, ENST00000359596, | |
Fusion gene scores | * DoF score | 28 X 17 X 13=6188 | 8 X 6 X 5=240 |
# samples | 30 | 8 | |
** MAII score | log2(30/6188*10)=-4.36643879095316 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/240*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ACTN4 [Title/Abstract] AND RYR1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ACTN4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 22351778 |
Hgene | ACTN4 | GO:0048384 | retinoic acid receptor signaling pathway | 22351778 |
Hgene | ACTN4 | GO:0051272 | positive regulation of cellular component movement | 9508771 |
Tgene | RYR1 | GO:0001666 | response to hypoxia | 19120137 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LIHC | TCGA-ED-A7PX-01A | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000252699 | ENST00000355481 | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
In-frame | ENST00000252699 | ENST00000360985 | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
In-frame | ENST00000252699 | ENST00000359596 | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
In-frame | ENST00000424234 | ENST00000355481 | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
In-frame | ENST00000424234 | ENST00000360985 | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
In-frame | ENST00000424234 | ENST00000359596 | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
In-frame | ENST00000390009 | ENST00000355481 | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
In-frame | ENST00000390009 | ENST00000360985 | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
In-frame | ENST00000390009 | ENST00000359596 | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
intron-3CDS | ENST00000497637 | ENST00000355481 | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
intron-3CDS | ENST00000497637 | ENST00000360985 | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
intron-3CDS | ENST00000497637 | ENST00000359596 | ACTN4 | chr19 | 39138547 | + | RYR1 | chr19 | 39051753 | + |
Top |
FusionProtFeatures for ACTN4_RYR1 |
![]() |
Hgene | Tgene |
ACTN4 | RYR1 |
F-actin cross-linking protein which is thought to anchoractin to a variety of intracellular structures. This is a bundlingprotein (Probable). Probably involved in vesicular trafficking viaits association with the CART complex. The CART complex isnecessary for efficient transferrin receptor recycling but not forEGFR degradation (PubMed:15772161). Involved in tight junctionassembly in epithelial cells probably through interaction withMICALL2. Links MICALL2 to the actin cytoskeleton and recruits itto the tight junctions (By similarity). May also function as atranscriptional coactivator, stimulating transcription mediated bythe nuclear hormone receptors PPARG and RARA (PubMed:22351778).{ECO:0000250|UniProtKB:P57780, ECO:0000269|PubMed:15772161,ECO:0000269|PubMed:22351778, ECO:0000305|PubMed:9508771}. | Calcium channel that mediates the release of Ca(2+) fromthe sarcoplasmic reticulum into the cytoplasm and thereby plays akey role in triggering muscle contraction following depolarizationof T-tubules (PubMed:11741831, PubMed:16163667). Repeated veryhigh-level exercise increases the open probability of the channeland leads to Ca(2+) leaking into the cytoplasm (PubMed:18268335).Can also mediate the release of Ca(2+) from intracellular storesin neurons, and may thereby promote prolonged Ca(2+) signaling inthe brain. Required for normal embryonic development of musclefibers and skeletal muscle. Required for normal heartmorphogenesis, skin development and ossification duringembryogenesis (By similarity). {ECO:0000250|UniProtKB:E9PZQ0,ECO:0000269|PubMed:18268335, ECO:0000305|PubMed:11741831,ECO:0000305|PubMed:16163667}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 19_26 | 54 | 912 | Compositional bias | Poly-Gly |
Hgene | ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 19_26 | 54 | 693 | Compositional bias | Poly-Gly |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4462_4532 | 4089 | 5034 | Compositional bias | Note=Pro-rich |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4462_4532 | 4094 | 5039 | Compositional bias | Note=Pro-rich |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4462_4532 | 4089 | 5034 | Compositional bias | Note=Pro-rich |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4881_4900 | 4089 | 5034 | Intramembrane | Pore-forming |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4881_4900 | 4094 | 5039 | Intramembrane | Pore-forming |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4881_4900 | 4089 | 5034 | Intramembrane | Pore-forming |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4895_4901 | 4089 | 5034 | Motif | Selectivity filter |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4895_4901 | 4094 | 5039 | Motif | Selectivity filter |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4895_4901 | 4089 | 5034 | Motif | Selectivity filter |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4210_4214 | 4089 | 5034 | Nucleotide binding | ATP |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4955_4960 | 4089 | 5034 | Nucleotide binding | ATP |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4980_4986 | 4089 | 5034 | Nucleotide binding | ATP |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4210_4214 | 4094 | 5039 | Nucleotide binding | ATP |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4955_4960 | 4094 | 5039 | Nucleotide binding | ATP |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4980_4986 | 4094 | 5039 | Nucleotide binding | ATP |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4210_4214 | 4089 | 5034 | Nucleotide binding | ATP |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4955_4960 | 4089 | 5034 | Nucleotide binding | ATP |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4980_4986 | 4089 | 5034 | Nucleotide binding | ATP |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4581_4641 | 4089 | 5034 | Topological domain | Lumenal |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4663_4780 | 4089 | 5034 | Topological domain | Cytoplasmic |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4804_4804 | 4089 | 5034 | Topological domain | Lumenal |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4822_4836 | 4089 | 5034 | Topological domain | Cytoplasmic |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4858_4880 | 4089 | 5034 | Topological domain | Lumenal |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4901_4920 | 4089 | 5034 | Topological domain | Lumenal |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4942_5038 | 4089 | 5034 | Topological domain | Cytoplasmic |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4581_4641 | 4094 | 5039 | Topological domain | Lumenal |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4663_4780 | 4094 | 5039 | Topological domain | Cytoplasmic |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4804_4804 | 4094 | 5039 | Topological domain | Lumenal |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4822_4836 | 4094 | 5039 | Topological domain | Cytoplasmic |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4858_4880 | 4094 | 5039 | Topological domain | Lumenal |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4901_4920 | 4094 | 5039 | Topological domain | Lumenal |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4942_5038 | 4094 | 5039 | Topological domain | Cytoplasmic |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4581_4641 | 4089 | 5034 | Topological domain | Lumenal |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4663_4780 | 4089 | 5034 | Topological domain | Cytoplasmic |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4804_4804 | 4089 | 5034 | Topological domain | Lumenal |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4822_4836 | 4089 | 5034 | Topological domain | Cytoplasmic |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4858_4880 | 4089 | 5034 | Topological domain | Lumenal |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4901_4920 | 4089 | 5034 | Topological domain | Lumenal |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4942_5038 | 4089 | 5034 | Topological domain | Cytoplasmic |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4560_4580 | 4089 | 5034 | Transmembrane | Helical%3B Name%3D1 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4642_4662 | 4089 | 5034 | Transmembrane | Helical%3B Name%3D2 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4781_4803 | 4089 | 5034 | Transmembrane | Helical%3B Name%3D3 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4805_4821 | 4089 | 5034 | Transmembrane | Helical%3B Name%3D4 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4837_4857 | 4089 | 5034 | Transmembrane | Helical%3B Name%3D5 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4921_4941 | 4089 | 5034 | Transmembrane | Helical%3B Name%3D6 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4560_4580 | 4094 | 5039 | Transmembrane | Helical%3B Name%3D1 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4642_4662 | 4094 | 5039 | Transmembrane | Helical%3B Name%3D2 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4781_4803 | 4094 | 5039 | Transmembrane | Helical%3B Name%3D3 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4805_4821 | 4094 | 5039 | Transmembrane | Helical%3B Name%3D4 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4837_4857 | 4094 | 5039 | Transmembrane | Helical%3B Name%3D5 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4921_4941 | 4094 | 5039 | Transmembrane | Helical%3B Name%3D6 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4560_4580 | 4089 | 5034 | Transmembrane | Helical%3B Name%3D1 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4642_4662 | 4089 | 5034 | Transmembrane | Helical%3B Name%3D2 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4781_4803 | 4089 | 5034 | Transmembrane | Helical%3B Name%3D3 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4805_4821 | 4089 | 5034 | Transmembrane | Helical%3B Name%3D4 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4837_4857 | 4089 | 5034 | Transmembrane | Helical%3B Name%3D5 |
Tgene | >RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4921_4941 | 4089 | 5034 | Transmembrane | Helical%3B Name%3D6 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 778_789 | 54 | 912 | Calcium binding | 1 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 819_830 | 54 | 912 | Calcium binding | 2 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 778_789 | 54 | 693 | Calcium binding | 1 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 819_830 | 54 | 693 | Calcium binding | 2 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 163_269 | 54 | 912 | Domain | Calponin-homology (CH) 2 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 50_154 | 54 | 912 | Domain | Calponin-homology (CH) 1 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 765_800 | 54 | 912 | Domain | EF-hand 1 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 806_841 | 54 | 912 | Domain | EF-hand 2 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 163_269 | 54 | 693 | Domain | Calponin-homology (CH) 2 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 50_154 | 54 | 693 | Domain | Calponin-homology (CH) 1 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 765_800 | 54 | 693 | Domain | EF-hand 1 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 806_841 | 54 | 693 | Domain | EF-hand 2 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 84_88 | 54 | 912 | Motif | LXXLL motif |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 84_88 | 54 | 693 | Motif | LXXLL motif |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 177_192 | 54 | 912 | Region | Polyphosphoinositide (PIP2)-binding |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 1_269 | 54 | 912 | Region | Note=Actin-binding |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 177_192 | 54 | 693 | Region | Polyphosphoinositide (PIP2)-binding |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 1_269 | 54 | 693 | Region | Note=Actin-binding |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 293_403 | 54 | 912 | Repeat | Spectrin 1 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 413_518 | 54 | 912 | Repeat | Spectrin 2 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 528_639 | 54 | 912 | Repeat | Spectrin 3 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 649_752 | 54 | 912 | Repeat | Spectrin 4 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 293_403 | 54 | 693 | Repeat | Spectrin 1 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 413_518 | 54 | 693 | Repeat | Spectrin 2 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 528_639 | 54 | 693 | Repeat | Spectrin 3 |
Hgene | >ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 649_752 | 54 | 693 | Repeat | Spectrin 4 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 1873_1924 | 4089 | 5034 | Compositional bias | Note=Glu-rich (acidic) |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 1873_1924 | 4094 | 5039 | Compositional bias | Note=Glu-rich (acidic) |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 1873_1924 | 4089 | 5034 | Compositional bias | Note=Glu-rich (acidic) |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 1013_1208 | 4089 | 5034 | Domain | B30.2/SPRY 2 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 1356_1570 | 4089 | 5034 | Domain | B30.2/SPRY 3 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 159_204 | 4089 | 5034 | Domain | MIR 2 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 210_264 | 4089 | 5034 | Domain | MIR 3 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 270_327 | 4089 | 5034 | Domain | MIR 4 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 335_392 | 4089 | 5034 | Domain | MIR 5 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 4074_4102 | 4089 | 5034 | Domain | EF-hand |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 581_797 | 4089 | 5034 | Domain | B30.2/SPRY 1 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 97_152 | 4089 | 5034 | Domain | MIR 1 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 1013_1208 | 4094 | 5039 | Domain | B30.2/SPRY 2 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 1356_1570 | 4094 | 5039 | Domain | B30.2/SPRY 3 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 159_204 | 4094 | 5039 | Domain | MIR 2 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 210_264 | 4094 | 5039 | Domain | MIR 3 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 270_327 | 4094 | 5039 | Domain | MIR 4 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 335_392 | 4094 | 5039 | Domain | MIR 5 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 4074_4102 | 4094 | 5039 | Domain | EF-hand |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 581_797 | 4094 | 5039 | Domain | B30.2/SPRY 1 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 97_152 | 4094 | 5039 | Domain | MIR 1 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 1013_1208 | 4089 | 5034 | Domain | B30.2/SPRY 2 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 1356_1570 | 4089 | 5034 | Domain | B30.2/SPRY 3 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 159_204 | 4089 | 5034 | Domain | MIR 2 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 210_264 | 4089 | 5034 | Domain | MIR 3 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 270_327 | 4089 | 5034 | Domain | MIR 4 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 335_392 | 4089 | 5034 | Domain | MIR 5 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 4074_4102 | 4089 | 5034 | Domain | EF-hand |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 581_797 | 4089 | 5034 | Domain | B30.2/SPRY 1 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 97_152 | 4089 | 5034 | Domain | MIR 1 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 841_2959 | 4089 | 5034 | Region | Note=6 X approximate repeats |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 841_2959 | 4094 | 5039 | Region | Note=6 X approximate repeats |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 841_2959 | 4089 | 5034 | Region | Note=6 X approximate repeats |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 1344_1359 | 4089 | 5034 | Repeat | Note=3%3B truncated |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 1372_1387 | 4089 | 5034 | Repeat | Note=4%3B truncated |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 2726_2845 | 4089 | 5034 | Repeat | Note=5 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 2846_2959 | 4089 | 5034 | Repeat | Note=6 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 841_954 | 4089 | 5034 | Repeat | Note=1 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 955_1068 | 4089 | 5034 | Repeat | Note=2 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 1344_1359 | 4094 | 5039 | Repeat | Note=3%3B truncated |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 1372_1387 | 4094 | 5039 | Repeat | Note=4%3B truncated |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 2726_2845 | 4094 | 5039 | Repeat | Note=5 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 2846_2959 | 4094 | 5039 | Repeat | Note=6 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 841_954 | 4094 | 5039 | Repeat | Note=1 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 955_1068 | 4094 | 5039 | Repeat | Note=2 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 1344_1359 | 4089 | 5034 | Repeat | Note=3%3B truncated |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 1372_1387 | 4089 | 5034 | Repeat | Note=4%3B truncated |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 2726_2845 | 4089 | 5034 | Repeat | Note=5 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 2846_2959 | 4089 | 5034 | Repeat | Note=6 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 841_954 | 4089 | 5034 | Repeat | Note=1 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 955_1068 | 4089 | 5034 | Repeat | Note=2 |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 1_4559 | 4089 | 5034 | Topological domain | Cytoplasmic |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 1_4559 | 4094 | 5039 | Topological domain | Cytoplasmic |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 1_4559 | 4089 | 5034 | Topological domain | Cytoplasmic |
Top |
FusionGeneSequence for ACTN4_RYR1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ACTN4_RYR1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
ACTN4 | MYOZ2, MYOZ1, PDLIM1, USP6NL, SLC9A3R2, COL17A1, TRIM3, MAGI1, GSN, CAMK2A, CAMK2B, INO80, UBTF, STAT1, HDAC7, MEF2A, UCHL5, TJP1, ATXN7, HDAC5, VDR, ESR1, PSMA3, ELAVL1, SIRT7, SLC2A4, ISG15, COIL, SACS, HGS, UBASH3B, SHC1, NOS3, ACTN2, ACTN1, FMNL1, TRAF3IP1, FN1, VCAM1, CDH1, ITGA4, SVIL, CD81, IGSF8, ICAM1, TXN, RPS27, POT1, KPNA2, MAPK7, CDKN2A, VCP, SF3A3, GNB2, HUWE1, ACTN3, BMP7, ALK, CUL7, OBSL1, CCDC8, EGFR, LUZP4, RARA, HSPB1, AHNAK, ALDOA, ALDOC, IDH3A, MYH15, MYH2, MYH7B, NCAPG2, PSMA6, PSMB5, PUS7, TPM2, TSG101, CKB, CYC1, ECSIT, MCFD2, PSMB8, TPM1, TPM3, TPM4, NTRK1, CAPZA2, DBN1, FLNA, MYH9, MYO1C, PPP1CB, IQGAP1, PDLIM7, SYNPO, MAPRE1, SIN3B, MYEF2, LIMA1, ANLN, MYO5C, MYO19, MYO18A, CTNNB1, MCM2, NFYA, CDC73, DDIAS, SSH1, NCL, DLD, DNM1L, PDHA1, SOD1, TRIM25, TES | RYR1 | TRDN, HOMER1, FKBP1A, RYR2, S100A1, HOMER2, HOMER3, ANK1, CALM1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Hgene | ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 12_26 | 54 | 912 | VCL |
Hgene | ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 12_26 | 54 | 693 | VCL |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 108_126 | 54 | 912 | VCL |
Hgene | ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000252699 | + | 1 | 21 | 40_61 | 54 | 912 | VCL |
Hgene | ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 108_126 | 54 | 693 | VCL |
Hgene | ACTN4 | chr19:39138547 | chr19:39051753 | ENST00000390009 | + | 1 | 14 | 40_61 | 54 | 693 | VCL |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 3614_3643 | 4089 | 5034 | CALM |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 3614_3643 | 4094 | 5039 | CALM |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 3614_3643 | 4089 | 5034 | CALM |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000355481 | + | 87 | 105 | 669_680 | 4089 | 5034 | FKBP1A |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000359596 | + | 88 | 106 | 669_680 | 4094 | 5039 | FKBP1A |
Tgene | RYR1 | chr19:39138547 | chr19:39051753 | ENST00000360985 | + | 87 | 105 | 669_680 | 4089 | 5034 | FKBP1A |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ACTN4_RYR1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | RYR1 | P21817 | DB00201 | Caffeine | Ryanodine receptor 1 | small molecule | approved |
Tgene | RYR1 | P21817 | DB01219 | Dantrolene | Ryanodine receptor 1 | small molecule | approved|investigational |
Tgene | RYR1 | P21817 | DB04786 | Suramin | Ryanodine receptor 1 | small molecule | approved|investigational |
Tgene | RYR1 | P21817 | DB09085 | Tetracaine | Ryanodine receptor 1 | small molecule | approved|vet_approved |
Top |
RelatedDiseases for ACTN4_RYR1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ACTN4 | C0333497 | Segmental glomerulosclerosis | 3 | UNIPROT |
Hgene | ACTN4 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Hgene | ACTN4 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Tgene | RYR1 | C0024591 | Malignant hyperpyrexia due to anesthesia | 49 | CTD_human;HPO;ORPHANET;UNIPROT |
Tgene | RYR1 | C0751951 | Central Core Myopathy (disorder) | 37 | CTD_human;ORPHANET;UNIPROT |
Tgene | RYR1 | C1850674 | MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA (disorder) | 3 | CTD_human;ORPHANET;UNIPROT |
Tgene | RYR1 | C0007134 | Renal Cell Carcinoma | 1 | CTD_human |
Tgene | RYR1 | C0752282 | Congenital Structural Myopathy | 1 | CTD_human |